Showing results for: Pharmaceutical Systems
Communities of practice are defined as groups of people who interact regularly to share information, insight, experience and tools about an area of common interest (Wenger 2002). Each community of practice is unique in terms of its formation, structure, and character (click here to learn more about managing and measuring communities). All communities, in some [more…]
Read More...
Using a people-centered approach, MSH works with local partners to develop health systems solutions that meet the needs of communities affected by TB. Strengthening national, regional, district, and local health managers and their institutions to provide quality health services is a core strategy to support health systems resilience and sustainability. MSH has developed materials highlighting [more…]
Read More...
The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector easily access and use already available SIAPS resources, including tools, experiences, and results. The document is also intended to serve as a technical legacy for SIAPS to support knowledge exchange and sustainability of related work. [more…]
Read More...
The UN adoption of the SDGs in 2015 signaled a strong commitment of member countries to the expanded access to essential health service agenda and definitively recognized the critical role of medicines in achieving UHC. The SDGs call for countries to “achieve universal health coverage, including financial risk protection, access to quality essential health care [more…]
Read More...
This guide will assist program managers, service providers, and technical experts when conducting a quantification of commodity needs for the 13 reproductive, maternal, newborn, and child health commodities prioritized by the UN Commission on Life-Saving Commodities for Women and Children. These 13 commodities have diverse characteristics: some are new products that are in the process [more…]
Read More...
Market Bookshelf is a growing open-access collection of health market literature. It was developed to give the many different market players across the global health community easier access to the analyses, reports, guidance, and tools created to understand and participate in different health markets. The up-to-date collection offers documents from key sources as well as [more…]
Read More...
The USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program and its predecessor programs have assisted numerous countries in strengthening governance to promote robust decision making, enhance accountability, reduce opportunities for corruption, and improve efficiencies to enable better access to and use of quality-assured medicines. This compendium draws on these experiences and provides [more…]
Read More...
Strengthening pharmaceutical systems entails implementing strategies and actions across critical components and functions of a system to improve and sustain performance and achieve better health outcomes. What is the evidence base for strengthening and sustaining responsive and resilient pharmaceutical systems? To answer this question, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) [more…]
Read More...
QuanTB is an electronic quantification and early warning system designed to improve procurement processes, ordering, and supply planning for TB treatment. Created by the USAID-funded Systems for Improved Access to Pharmaceutical and Services (SIAPS) Program, QuanTB is a downloadable desktop tool that transforms complicated calculations into user-friendly graphs displaying key information for managing medicines. When used on a regular basis (e.g., monthly, quarterly), QuanTB serves as an early warning system, providing information on actual versus planned consumption, potential expiries, and stock outs of medicines.
Read More...
This fact sheet provides information about misoprostol’s critical role in preventing and treating postpartum bleeding or hemorrhage (PPH), one of the leading causes of maternal death worldwide. Misoprostol, a medicine initially developed to prevent stomach ulcers, is often the best available option for preventing and treating PPH in many low-resource countries, and may be a [more…]
Read More...